PRAX · Praxis Precision Medicines, Inc. · Webcasts, Transcripts & Audio
$328.13
+3.37 (+1.04%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$9.17B
Shares
27.95M
Volume · Nov 13
352.89K
Avg daily vol (3M)
458.44K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Praxis Precision Medicines, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Praxis Precision Medicines, Inc. (PRAX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-18
Praxis Precision Medicines, Inc. (PRAX) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-16
Praxis Precision Medicines, Inc. (PRAX) November 16, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Capital Markets Day
Investor event
2026-11-12
Praxis Precision Medicines, Inc. (PRAX) November 12, 2026 Capital Markets Day
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-09
Praxis Precision Medicines, Inc. (PRAX) November 9, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call Transcript
Confident tone
Commercial launch readiness
Ulexacaltamide (Essential Tremor) NDA
Relutrogene (SCN2A/8A) NDA and PDUFA
Diluted EPS
$-2.87
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Praxis Precision Medicines, Inc. (PRAX) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-08
Praxis Precision Medicines, Inc. (PRAX) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Praxis Precision Medicines, Inc. (PRAX) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Praxis Precision Medicines, Inc. (PRAX) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript
Confident tone
Vormatrigene (POWER 1/2/3) program
Uliexacaltamide for Essential Tremor
Emerald broad DE study enrollment
Diluted EPS
$-3.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
Praxis Precision Medicines, Inc. (PRAX) Q4 2025 Earnings Call Transcript
Confident tone
Relutrigine in DEEs
Ulixacaltamide in essential tremor
Regulatory and FDA interactions
Revenue
$0*
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-24
Praxis Precision Medicines, Inc. (PRAX) Q3 2025 Earnings Call
Revenue
$0
▼ 100% YoY Diluted EPS
$-3.36
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Praxis Precision Medicines, Inc. (PRAX) Q2 2025 Earnings Call Transcript
Confident tone
RADIANT study efficacy results
Pipeline and upcoming catalysts
Safety and tolerability profile
Revenue
$0
▼ 100% YoY Diluted EPS
$-3.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-11-06
Praxis Precision Medicines, Inc. (PRAX) Q3 2024 Earnings Call Transcript
Confident tone
Ulixacaltamide Phase 3 Essential Tremor Program
Relutrigine in SCN2A and SCN8A DEEs
Vormatrigine (PRAX-628) ENERGY Program in Epilepsy
Revenue
$302,000
▼ 35.5% YoY Diluted EPS
$-2.75
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Praxis Precision Medicines, Inc. (PRAX) Q2 2024 Earnings Call
Revenue
$357,000
▼ 54.3% YoY Diluted EPS
$-1.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Praxis Precision Medicines, Inc. (PRAX) Q1 2022 Earnings Call Transcript
Revenue
$0
Diluted EPS
$-22.65
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
Praxis Precision Medicines, Inc. (PRAX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Praxis Precision Medicines, Inc. (PRAX) Q3 2021 Earnings Call Transcript
Diluted EPS
$-15.00
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-17
Praxis Precision Medicines, Inc. (PRAX) Q4 2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–19 of 19 webcasts
Key facts
CIK
1689548
CUSIP
74006W207
13F (30d)
252 filings
231 filers
Visit website
Investor relations